FDA Adverse Event Injury Summary report: N

DUROM ACETABULAR COMPONENT 54/48 CODE N

MDR report key: 2871532 · Received December 6, 2012

Report

Report Number
9613350-2012-01129
Event Type
Injury
Date Received
December 6, 2012
Date of Event
November 26, 2012
Report Date
November 27, 2012
Manufacturer
ZIMMER GMBH
Product Code
KWA
Removal / Correction Number
Z-2415/2426-2008
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NZ
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE MANUFACTURER DID NOT RECEIVE THE DEVICE. THE LOT NUMBERS WERE RECEIVED FOR THE DEVICE AND THE DEVICE HISTORY RECORDS WERE REVIEWED AND FOUND TO BE CONFORMING. THE CAUSE FOR THIS SPECIFIC CLINICAL EVENT CANNOT BE ASCERTAINED FROM THE INFORMATION PROVIDED AND A PRODUCT FAILURE CANNOT BE CONFIRMED. A TIGHT MONITORING IS ONGOING FOR REVISIONS WITH EU DUROM CUPS WHERE THE INITIAL IMPLANT DATE OCCURRED AFTER THE ACCOMPLISHMENT OF A RETRAINING PROGRAM FOR USERS OUTSIDE THE U.S. WHICH WAS INITIATED IN NOVEMBER 2009 AS A CORRECTIVE ACTION AND REPORTED TO THE NATIONAL COMPETENT AUTHORITIES AS REQUIRED. THE DUROM CUP REPORTED IN THIS CASE IS NOT MARKETED IN THE U.S. A SIMILAR CUP, COMPATIBLE WITH THE METASUL LDH FEMORAL HEAD, IS CLEARED IN THE U.S. AND A CORRECTIVE ACTION FOR THIS PRODUCT WAS REPORTED TO THE FDA IN JULY 2008 AS CORRECTION Z-2415/2426-2008. THE NEED FOR FURTHER CORRECTIVE MEASURES IS NOT INDICATED AND ZIMMER GMBH CONSIDERS THIS CASE AS CLOSED. ZIMMER REFERENCE NUMBER (B)(4).

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PT RECEIVED A DUROM ACETABULAR COMPONENT 54/48 CODE N ON (B)(6) 2010 AND UNDERWENT REVISION SURGERY ON (B)(6) 2012 DUE TO HETEROTROPIC OSSIFICATION AND LEG-LENGTH DISCREPANCY. IT WAS ALSO NOTED THAT THERE WAS "OBVIOUS BLACK TISSUE AND STAINING AROUND THE TRUNNION OF THE FEMORAL STEM IMPLANT."

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 DUROM ACETABULAR COMPONENT 54/48 CODE N DUROM ACETABULAR COMPONENT AND METASUL KWA ZIMMER GMBH 2471848

Patients

Seq Age Sex Outcome Treatment
1 59 YR Hospitalization| R